SPY314.38-1.80 -0.57%
DIA257.24-3.48 -1.33%
IXIC10,547.75+55.25 0.53%

B of A Securities Reinstates Buy on Rocket Pharmaceuticals, Announces $34 Price Target

B of A Securities analyst Greg Harrison reinstates Rocket Pharmaceuticals (NASDAQ:RCKT) with a Buy and announces $34 price target.

Benzinga · -
B of A Securities analyst Greg Harrison reinstates Rocket Pharmaceuticals (NASDAQ: RCKT) with a Buy and announces $34 price target.